INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo SENNALAX TABLETS

SCHEDULING STATUS:
Not scheduled.

PROPRIETARY NAME:
(and dosage form)

SENNALAX TABLETS

COMPOSITION:
Each tablet contains
Senna Dry Extract containing Sennosides A and B equivalent to 7,5 mg Sennoside B.

PHARMACOLOGICAL CLASSIFICATION:
A 11.5 Laxatives.

PHARMACOLOGICAL ACTION:
Sennosides A and B are a natural complex of anthraquinone glycosides found in senna.
The active ingredients (vis. Glycosides) are absorbed from the intestinal tract and the active anthraquinones liberated in the course of breakdown are excreted largely into the colon, which is thereby stimulated.

INDICATIONS:
Constipation.

CONTRA-INDICATIONS:
Undiagnosed abdominal pains and patients with symptoms of appendicitis or intestinal obstruction, nausea and vomiting.

WARNINGS:
Frequent or prolonged use of this preparation may result in dependence on laxatives. If you have noticed a sudden change in bowel habits that has persisted for a period of longer than two weeks, consult a doctor before using the laxative.

DOSAGE AND DIRECTIONS FOR USE:
Adults
The usual dose is between 2 to 4 tablets which may be increased or decreased depending on the response.
Children over the age of 6 years
Half the adult dose.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
The constant use of laxatives to induce a regular daily habit may decrease the sensitivity of the intestinal mucous membranes so that larger doses have to be taken and the bowel fails to respond to normal stimuli.
Abdominal cramps and flatulence may occur.
Melanosis coli and coloration of the urine and faeces have followed the use of Sennalax Tablets.
In the event of continued constipation after the use of this drug for a period of more than one week, consult a physician.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Severe diarrhoea and electrolyte disturbances.
Treatment must be symptomatic with fluid and electrolyte replacement.

IDENTIFICATION:
Thick khaki coloured biconvex tablet.

PRESENTATION:
Packs of 12 tablets.

STORAGE INSTRUCTIONS:
KEEP OUT OF REACH OF CHILDREN

REGISTRATION NUMBER:
Y/11.5/80

NAME AND BUSINESS ADDRESS OF APPLICANT:
Lennon Limited
7 Fairclough Road
PORT ELIZABETH
6001

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
24/7/1990 K95

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996,1997,1998